Press release AFFLUENT MEDICAL
Affluent Medical announces the initiation of coverage of its title by Portzamparc – BNP Paribas Group.
Portzamparc – BNP Paribas Group initiated monitoring of the stock with a study entitled: “Close to your heart” published on November 24, 2023. In this study, Portzamparc – BNP Paribas Group recommends the stock for purchase, with an objective price of €3.60, representing an upside potential of 188% compared to the closing price of November 23, 2023.